[Bone mineral density in children with osteogenesis imperfecta]

Area of Science:

• Biochemistry
• Pediatric Endocrinology
• Orthopedics

Background:

• Osteogenesis imperfecta (OI) is a group of inherited disorders characterized by defective collagen synthesis, leading to brittle bones.
• Increased bone fragility is a hallmark of OI, necessitating accurate methods for bone mineral density (BMD) assessment.

Purpose of the Study:

• To evaluate the bone mineral density (BMD) in pediatric patients diagnosed with osteogenesis imperfecta (OI).
• To assess the utility of dual-energy X-ray absorptiometry (DEXA) in measuring BMD in children with OI.

Main Methods:

• Bone mineral density (BMD) was measured using dual-energy X-ray absorptiometry (DEXA) in 8 patients with OI (ages 3-20).
• A control group, matched for age and sex, was used for comparison.
• Statistical analysis was performed using the Wilcoxon test.

Main Results:

• Patients with OI exhibited significantly lower mean BMD compared to the age and sex-matched control group.
• The mean BMD in OI patients was 62.6% of normal in the lumbar spine (p < 0.01).
• The mean BMD in OI patients was 63.01% of normal in the femoral neck (p < 0.01).

Conclusions:

• Dual-energy X-ray absorptiometry (DEXA) is an objective, reproducible, and sensitive method for measuring BMD in children.
• DEXA can aid in establishing the diagnosis of OI, assessing prognosis, and monitoring treatment response.